WHO ICTRP trial
Clinical and pathological response of pre-operative intratumoral and…
TCTR20220202004 · Thai Clinical Trials Registry (TCTR)
Key facts
| Trial ID | TCTR20220202004 |
|---|---|
| Public title | Clinical and pathological response of pre-operative intratumoral and intramuscular Poly-ICLC (Hiltonol) for cutaneous melanoma stage 2 and 3 |
| Scientific title | Clinical and pathological response of pre-operative Intratumoral and Intramuscular Poly-ICLC(Hiltonol) for cutaneous melanoma stage 2 and 3 |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | cutaneous melanoma stage 2 and 3 cutaneous melanoma melanoma stage 2 and 3 Hiltonol poly-ICLC immunotherapy neoantigen therapeutic cancer vaccine ;cutaneous melanoma melanoma stage 2 and 3 Hiltonol poly-ICLC immunotherapy neoantigen… |
| Interventions | the patient will receive Poly-ICLC (Hiltonol) 1 mg (0. 5 ml) intratumoral injection 3 times/week in first 2 weeks, then Poly-ICLC (Hiltonol) 1 mg (0. 5 ml) intramuscular injection 2 timess/week in following 2 weeks before go on surgery in… |
| Registration date | Feb 2, 2022 |
| Target size | 12 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: